Correlation Between Ikena Oncology and Protagenic Therapeutics

Can any of the company-specific risk be diversified away by investing in both Ikena Oncology and Protagenic Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ikena Oncology and Protagenic Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ikena Oncology and Protagenic Therapeutics, you can compare the effects of market volatilities on Ikena Oncology and Protagenic Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ikena Oncology with a short position of Protagenic Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ikena Oncology and Protagenic Therapeutics.

Diversification Opportunities for Ikena Oncology and Protagenic Therapeutics

0.05

Correlation Coefficient

Ikena Oncology  Protagenic Therapeutics

Significant diversification

The 3 months correlation between Ikena and Protagenic is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Ikena Oncology and Protagenic Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protagenic Therapeutics and Ikena Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ikena Oncology are associated (or correlated) with Protagenic Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protagenic Therapeutics has no effect on the direction of Ikena Oncology i.e., Ikena Oncology and Protagenic Therapeutics go up and down completely randomly.

Pair Corralation between Ikena Oncology and Protagenic Therapeutics

Given the investment horizon of 90 days Ikena Oncology is expected to generate 0.14 times more return on investment than Protagenic Therapeutics. However, Ikena Oncology is 7.21 times less risky than Protagenic Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Protagenic Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  169.00  in Ikena Oncology on September 13, 2024 and sell it today you would earn a total of  1.00  from holding Ikena Oncology or generate 0.59% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ikena Oncology  vs.  Protagenic Therapeutics

Ikena Oncology

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Ikena Oncology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Ikena Oncology is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Protagenic Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Protagenic Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Ikena Oncology and Protagenic Therapeutics

The main advantage of trading using opposite Ikena Oncology and Protagenic Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ikena Oncology position performs unexpectedly, Protagenic Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protagenic Therapeutics will offset losses from the drop in Protagenic Therapeutics' long position.

The idea behind Ikena Oncology and Protagenic Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.